21 hasil untuk "Yusuke Enta"

Venography and Selective Ablation for Recurrent Varices after Surgery Using Radiofrequency Ablation Catheter

Yusuke Enta; Makoto Saigan; Akiko Tanaka dkk.

Case Reports in Vascular Medicine, Vol. 2021 · 2021 · Inggris · DOAJ

Recurrent varices after surgery (REVAS) is a common problem with no established treatment. Ultrasonography is a hard method to identify the source of veins that cause REVAS, especially in obese patients with thick thighs. Here, we report the case of a 64-year-old obese patient who previously…

Transcatheter aortic valve replacement in patients with severe aortic stenosis reduced the frequency of intradialytic hypotension

Makoto Saigan; Masaki Miyasaka; Tasuku Nagasawa dkk.

Scientific Reports, Vol. 14 No. 1 · 2024 · Inggris · DOAJ Scopus

Abstract Intradialytic hypotension (IDH) is a common complication during hemodialysis that increases cardiovascular morbidity and mortality. Aortic stenosis (AS) is a cause of IDH. Transcatheter aortic valve replacement (TAVR) has become an established treatment for patients with severe AS…

Author Correction: Transcatheter aortic valve replacement in patients with severe aortic stenosis reduced the frequency of intradialytic hypotension

Makoto Saigan; Masaki Miyasaka; Tasuku Nagasawa dkk.

Scientific Reports, Vol. 14 No. 1 · 2024 · Inggris · DOAJ Scopus

Incidence and predictors of prosthesis–patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve

Yusuke Watanabe; Shinichi Shirai; Norio Tada dkk.

Open Heart, Vol. 8 No. 1 · 2021 · Inggris · DOAJ Scopus

Background The balloon-expandable SAPIEN 3 (S3) is superior to the older-generation balloon-expandable SAPIEN XT (XT) in a lower incidence of paravalvular aortic regurgitation, lower complication rates and better survival in transcatheter aortic valve implantation (TAVI). However…

Patients’ characteristics and mortality in urgent/emergent/salvage transcatheter aortic valve replacement: insight from the OCEAN-TAVI registry

Yusuke Watanabe; Shinichi Shirai; Norio Tada dkk.

Open Heart, Vol. 7 No. 2 · 2020 · Inggris · DOAJ Scopus

Objectives Patients’ backgrounds and clinical outcomes in urgent/emergent/salvage transcatheter aortic valve replacement (Em-TAVR) remain unclear. We investigated patient characteristics and the mortality in Em-TAVR and the predictors for the need for Em-TAVR.Methods We consecutively enrolled 1613…

Real‐World Outcomes of the Initial Clip Selection for Transcatheter Edge‐to‐Edge Repair Using the MitraClip G4 From the Optimized Catheter Valvular Intervention‐Mitral Registry

Shunsuke Kubo; Masanori Yamamoto; Mike Saji dkk.

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 14 No. 17 · 2025 · Inggris · DOAJ Scopus

Background The association of outcomes with initial clip selection has not been investigated in patients undergoing transcatheter edge‐to‐edge repair with the MitraClip G4. Methods We analyzed 2257 patients receiving the MitraClip G4 according to the initial clip type: short (NT/NTW) versus long…

Suitability for Transcarotid Transcatheter Aortic Valve Replacement in the Japanese Population

Masaki Nakashima, MD; Natsuko Satomi, MD; Daishi Tazawa, MD dkk.

JACC: Asia, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

Background: Transcarotid (TC) transcatheter aortic valve replacement (TAVR) has shown favorable outcomes in selected Western populations; however, data on its suitability in patients undergoing TAVR remain scarce. Objectives: The purpose of this study was to investigate the anatomical…

One‐Year Outcomes and Their Relationship to Residual Mitral Regurgitation After Transcatheter Edge‐to‐Edge Repair With MitraClip Device: Insights From the OCEAN‐Mitral Registry

Shunsuke Kubo; Masanori Yamamoto; Mike Saji dkk.

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 12 No. 20 · 2023 · Inggris · DOAJ Scopus

Background Limited data are available about clinical outcomes and residual mitral regurgitation (MR) after transcatheter edge‐to‐edge repair in the large Asian‐Pacific cohort. Methods and Results From the Optimized Catheter Valvular Intervention (OCEAN‐Mitral) registry, a total of 2150 patients…

Systemic Inflammation and Outcomes After Mitral Edge‐to‐Edge Repair: Insights From the OCEAN‐Mitral Registry

Kazunori Omote; Masanori Yamamoto; Atsushi Sugiura dkk.

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 15 No. 15 · 2026 · Inggris · DOAJ Scopus

Background Systemic inflammation is increasingly recognized as an important contributor to cardiovascular outcomes. High‐sensitivity CRP (C‐reactive protein) is an established biomarker, but its prognostic value after mitral transcatheter edge‐to‐edge repair remains unclear. Clinical parameters…

Prognostic Impact of Modified J‐MACS Score in Patients With Systolic Heart Failure Receiving Transcatheter Edge‐to‐Edge Mitral Valve Repair

Yohei Ueno; Teruhiko Imamura; Shuhei Tanaka dkk.

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 14 No. 19 · 2025 · Inggris · DOAJ Scopus

Background Given the relatively high morbidity and death associated with transcatheter edge‐to‐edge repair for secondary mitral regurgitation, the development of optimal risk stratification models is imperative. The J‐MACS (Japanese Registry for Mechanically Assisted Circulatory Support) score is a…

Clinical Impact of Baseline Frailty Status and Residual Mitral Regurgitation After Transcatheter Edge‐to‐Edge Repair: Insights From the OCEAN‐Mitral Registry

Takahiro Tokuda; Masanori Yamamoto; Ai Kagase dkk.

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 13 No. 21 · 2024 · Inggris · DOAJ Scopus

Background The Clinical Frailty Scale (CFS) is a useful frailty marker for predicting clinical outcomes in patients undergoing invasive therapy. However, the clinical impact of CFS after transcatheter edge‐to‐edge repair in patients with mitral regurgitation (MR) remains unclear. This study aimed…

Prognostic impact of being underweight in patients undergoing mitral TEER: The OCEAN‐Mitral registry

Ryosuke Higuchi; Masaki Izumo; Yuki Izumi dkk.

ESC Heart Failure, Vol. 12 No. 1 · 2025 · Inggris · DOAJ Scopus

Abstract Aims Mitral transcatheter edge‐to‐edge repair (M‐TEER) is a valid treatment option for severe mitral regurgitation (MR), necessitating accurate risk stratification of M‐TEER candidates for effective patient selection, optimal periprocedural care and improved long‐term outcomes. The body…

Safety and Prognostic Implications of Mechanical Circulatory Support‐Assisted Transcatheter Edge‐to‐Edge Repair: The OCEAN‐Mitral Registry

Shuhei Tanaka; Teruhiko Imamura; Ryuichi Ushijima dkk.

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 14 No. 24 · 2025 · Inggris · DOAJ Scopus

Background Transcatheter edge‐to‐edge repair of the mitral valve (M‐TEER) has demonstrated promising outcomes for patients with mitral regurgitation who are unsuitable for surgical intervention. However, the clinical implications of M‐TEER in patients requiring mechanical circulatory support (MCS)…

Impact of Transcatheter Edge‐to‐Edge Repair in Patients With Cardiac Sarcoidosis: Insights From the OCEAN‐Mitral Registry

Takashi Hiruma; Mike Saji; Mamoru Nanasato dkk.

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 14 No. 7 · 2025 · Inggris · DOAJ Scopus

Background In patients with sarcoidosis, cardiac involvement is a crucial prognostic factor leading to severe cardiovascular events. Mitral regurgitation (MR) predisposes patients to drug‐refractory heart failure; however, MR in patients with cardiac sarcoidosis (CS) has been scarcely investigated…

Clinical Impact of Early Changes in Serum Albumin on Patient Prognosis After Mitral‐Transcatheter Edge‐to‐Edge Repair

Kenichi Shibata; Masanori Yamamoto; Ai Kagase dkk.

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 14 No. 15 · 2025 · Inggris · DOAJ Scopus

Background Low serum albumin levels indicate frailty and are strong predictors of poor prognosis after mitral transcatheter edge‐to‐edge repair (M‐TEER); however, albumin levels are expected to improve in response to treatment for mitral regurgitation. No reports have elucidated the clinical…

Outcomes of Transcatheter Edge‐to‐Edge Repair in Potentially Favorable Candidates for Left Ventricular Assist Device: Evidence From the OCEAN‐Mitral Registry

Shuhei Tanaka; Teruhiko Imamura; Yuki Hida dkk.

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 15 No. 7 · 2026 · Inggris · DOAJ Scopus

Background Transcatheter edge‐to‐edge repair of the mitral valve (M‐TEER) has shown promising outcomes in patients with advanced heart failure and significant mitral regurgitation. Similarly, outcomes after left ventricular assist device (LVAD) implantation have improved in advanced heart failure…

Prognostic Value of the Meta‐Analysis Global Group in Chronic Heart Failure Risk Score in Patients Undergoing Mitral Valve Transcatheter Edge‐to‐Edge Repair

Yohei Nishimura; Masahiko Asami; Yu Horiuchi dkk.

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 15 No. 13 · 2026 · Inggris · DOAJ Scopus

Background The prognostic value of the Meta‐Analysis Global Group in Chronic Heart Failure (MAGGIC) score in patients undergoing mitral valve transcatheter edge‐to‐edge repair (M‐TEER) remains unclear. This study evaluated the MAGGIC score to predict outcomes after M‐TEER in patients with…

Plasma volume status predicting clinical outcomes in patients undergoing transcatheter edge‐to‐edge mitral valve repair

Ai Kagase; Masanori Yamamoto; Takahiro Tokuda dkk.

ESC Heart Failure, Vol. 12 No. 4 · 2025 · Inggris · DOAJ Scopus

Abstract Aims Plasma volume status (PVS) is recognized as a marker of systemic congestion, but its clinical utility in patients with mitral regurgitation (MR) undergoing transcatheter edge‐to‐edge mitral valve repair (M‐TEER) has not been well established. This study aimed to evaluate the…

Mitral Transcatheter Edge-to-Edge Repair in Ventricular Functional Mitral Regurgitation and Very Severe Left Ventricular Dysfunction

Kazunori Omote, MD; Masanori Yamamoto, MD; Atsushi Sugiura, MD dkk.

JACC: Advances, Vol. 5 No. 9 · 2026 · Inggris · DOAJ Scopus

Background: Patients with functional mitral regurgitation (MR) and very severe left ventricular (LV) dysfunction (LV ejection fraction [LVEF]

Geriatric Nutritional Risk Index Assessment in Patients Undergoing Transcatheter Edge-to-Edge Repair

Kenichi Shibata, PT; Masanori Yamamoto, MD; Ai Kagase, MD dkk.

JACC: Advances, Vol. 4 No. 4 · 2025 · Inggris · DOAJ Scopus

Background: Transcatheter edge-to-edge repair (TEER) is used to treat patients with mitral regurgitation (MR). The Geriatric Nutritional Risk Index (GNRI) is a well-known nutritional marker that predicts mortality risk. Objectives: The objectives of this study were to elucidate the clinical…